Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02677948 |
Title | Multicenter Study of Pacritinib Combined With Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) |
Recruitment | Withdrawn |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | University of Michigan Cancer Center |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |